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ABSTRACT
This study investigated the use of a rapid bacterial toxicity test for detecting disinfectant residues
released by disinfected materials. The test substances included an environmental disinfectant used in
hospitals in high-risk areas, such as critical care units or emergency services, and three disinfectants
used on clinical devices when a high level of disinfection is required. The test materials were
polyurethane, polypropylene, glass, latex and cotton from different instruments and utensils used in
hospitals. Of the four test disinfectants, o-phthalaldehyde (OPA) and 2-bromo-2-nitro-1,3-propanediol
(BNP) showed the greatest inhibitory activity (as much as 300-fold greater than hydrogen peroxide in
the case of OPA) according to the toxicity text. However, with the exception of hydrogen peroxide on
latex, it was the most porous test materials, namely latex and cotton, that accumulated the least residue.
BNP was the disinfectant that left the least residue on the five test materials, while the greatest residual
concentration was left by hydrogen peroxide on latex (as much as 5 lg ⁄ cm2). The biotest used in this
study permitted the detection of disinfectant residues released by different types of previously
disinfected clinical materials, and can be adapted to simulate elution conditions similar to those existing
in routine hospital practice.
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INTRODUCTION
Correct cleaning and disinfection of reusable
clinical equipment such as endoscopes, broncho-
scopes or anaesthetic instruments is essential if
the spread of pathogenic microorganisms is to be
avoided. The presence of organisms as diverse as
Pseudomonas aeruginosa, Mycobacterium tuberculosis
or Helicobacter pylori has been related to outbreaks
of nosocomial infection associated with instru-
ments of this type [1–3]. In general, the concen-
trations at which disinfectants are used on clinical
materials are established by susceptibility tests in
which a liquid medium is inoculated with a
suspension of microorganisms in the presence of
serial dilutions of the disinfectant in question.
However, disinfectants are less effective on solid
surfaces than in suspension tests, as can be seen in
the so-called surface tests designed to assess the
efficacy of biocides on solid materials [4].
Another problem related to the disinfection of
clinical devices, such as endoscopes or broncho-
scopes, or materials that come into close contact
with patients’ mucous membranes is the possi-
bility that disinfectant residues might cause
adverse reactions in patients. Although infre-
quent, cases of acute colitis have been described
that were probably caused by glutaraldehyde
(GTA) or hydrogen peroxide (HP) residues [5,6].
Allergic contact dermatitis or occupational asth-
ma related to GTA and other disinfectants have
also been reported [7,8]. In addition, most chem-
icals used to process endoscopes and similar
instruments irritate the skin, mucous membranes
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and respiratory tract, although these side effects
concern mostly the personnel in charge of the
sterilisation ⁄disinfection procedures.
Techniques used to detect the presence of
chemical residues generally require instruments
and methods that are too complicated for routine
use in hospitals with limited facilities. Simple
analytical techniques for use on medical devices
have been developed for only a few substances,
such as formaldehyde [9]. Bioassays based on the
use of indicator microorganisms have proved to
be an efficient screening tool for monitoring
different chemicals in water or sediments. Some
of these assays have also been used to monitor
extraction solvents used in the chemical and
biological examination of medical devices [10].
A toxicity test based on the fluorescence
produced by the glucuronidase activity of
Escherichia coli in the presence of a fluorogenic
substrate (4-methylumbelliferyl-b-D-glucuronide)
has recently been proposed as a surface toxicity
bioassay [11]. The purpose of the present study
was to investigate the capacity of this surface
biotest to detect disinfectant or chemical resi-
dues adhering to different materials associated
with clinical instruments such as probes, cathe-
ters, ventilation tubes, endoscopes or other
instruments that come into close contact with
the skin and mucous membranes of patients. To
assess this strategy, sample materials from some
of these instruments were treated with different
disinfectants and chemicals in accordance with
hospital protocols. The presence of residues was
determined by a toxicity biotest and, where
residues were detected, the concentration was
calculated by extrapolating the dose–response
curves obtained from known concentrations of
each of the test disinfectants.
MATERIALS AND METHODS
Preparation of disinfectants and carriers
The test disinfectants—all in aqueous solution—were GTA,
o-phthalaldehyde (OPA), HP and 2-bromo-2-nitro-1,3-pro-
panediol (BNP) (Sigma-Aldrich, Madrid, Spain). Surface bio-
tests were conducted with solutions prepared according to the
dilutions recommended for clinical use (i.e., GTA 2% v ⁄v,
OPA 0.5% v ⁄v, HP 3% v ⁄v and BNP 0.1% v ⁄v). The materials
used as carriers in the surface tests were polyurethane
penicylinders and polypropylene penicylinders from catheters
made by B. Braun Melsungen (Melsungen, Germany), glass
penicylinders (Albus, Cordoba, Spain), latex rubber and 100%
cotton material from hospital cloths. The materials were cut
into fragments of the same size with a scalpel under sterile
conditions. The measurements for calculating the surface area
of the carriers were taken with an electronic digital calliper
(Comecta, Barcelona, Spain).
Procedure for the surface biotest
Surface tests were performed as described previously [11]. In
brief, a fluorogenic bioassay involving the b-glucuronidase-
mediated conversion of 4-methylumbelliferyl-b-D-glucuronide
to 4-methylumbelliferone was used to evaluate the toxic effect
of the four disinfectants on E. coli. The assay is based on the
premise that there will be no fluorescence if a disinfected
carrier with residual traces of disinfectant at an inhibitory
concentration is introduced into a test tube containing meth-
ylumbelliferyl-b-D-glucuronide and E. coli. If the tube shows a
lower level of fluorescence than that emitted by control tubes
without disinfectant, it is possible to quantify the disinfectant
in relation to known concentrations of the test substance in
question.
Before the surface biotest was conducted, Eppendorf tubes
containing 1 mL of sterile nutrient broth supplemented with
NaCl (1 g ⁄L) and thymine (0.4 mg ⁄L) were inoculated with
E. coli strain W3110 thy– F– (Spanish Collection of Culture
Types, Valencia, Spain). Following incubation for 18 h at
37 C, 0.5 mL of sterile glycerine 50% v ⁄v was added to each
tube; the tubes were then stored at ) 20C until use. Immedi-
ately before use in the test, the tubes were thawed at 22C for
10 min and then centrifuged for 5 min at 3300 g. The precipi-
tate was resuspended in 5 mL of Vogel–Bonner minimal
medium (0.8 mM MgSO4.7H2O, 10 mM citric acid monohy-
drate, 57.4 mM K2HPO4, 3 mM NaNH4HPO4.4H2O) and held
at 4C. This bacterial suspension was used directly in the
assays. The viable count (1.3–2 · 108 CFU ⁄mL) was verified at
the beginning of each experiment by spreading ten-fold
dilutions in phosphate buffer on tryptic soy agar plates
(Oxoid, Basingstoke, UK) and incubating at 37C for 24 h.
Plate counts were performed in duplicate.
For the surface biotest, the carriers were dipped into a
sterile Erlenmeyer flask containing 50 mL of diluted disin-
fectant and left at 22C for 10 min. The carriers were then
removed and placed on a piece of sterile filter paper in a
Petri dish. Once dry (30 min at 22C was sufficient), they
were introduced separately into tubes containing 2 mL of
VBMT medium (Vogel–Bonner minimal medium supplemen-
ted with methylumbelliferyl-b-D-glucuronide 0.01 mg ⁄L and
thymine 0.05 mg ⁄L, both from Sigma-Aldrich) and shaken
vigorously for 10 s. An aliquot (1.8 mL) was then added to a
100 · 16 mm tube with a screw cap containing 0.2 mL of
bacterial suspension, and incubated in a shaking water bath
at 37C for 210 min. After incubation, the fluorescence of
each tube was measured in relative fluorescence units
(RFUs) with a model LS 30 fluorometer (Perkin Elmer,
Beaconsfield, UK), with excitation at 340 nm and emission at
445 nm, followed by subtraction of the fluorescence values of
the corresponding control tubes. Controls were prepared
simultaneously in sterile distilled water without disinfectant.
The concentration of the disinfectant released from each
type of carrier was calculated from the inhibition of E. coli
b-glucuronidase activity. The mean of the fluorescence
emission in RFUs of five replicates (with disinfectant) and
the mean of the corresponding controls (without disinfectant)
were used, and the results of the test were expressed as
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the percentage inhibition vs. controls (% inhibition:
(RFUdisinfectant ) RFUcontrol) · (100 ⁄RFUcontrol).
Simultaneously, a series of tubes of VBMT medium
(1.8 mL) containing serial dilutions of known disinfectant
concentrations were prepared for each test substance, except
for three tubes that were used as controls. Following inocu-
lation with 0.2 mL of bacterial suspension, the tubes were
incubated at 37C for 210 min, after which the fluorescence
was measured as described above. A dose–response curve was
obtained for each disinfectant from the percentage of inhibi-
tion vs. controls and the log10 of the corresponding disinfectant
concentrations. The dose–response curves for known disin-
fectant concentrations were obtained and the assays to deter-
mine the residual inhibition associated with each type of
carrier were carried out simultaneously for the five tests
conducted on each individual test material. The average
concentration of disinfectant released by each type of carrier
was calculated by regressing the percentage of inhibition,
corresponding to the log10 of known disinfectant concentra-
tions, using the regression line of the dose–response curve. The
antibacterial efficacy against E. coli W3110 of each disinfectant
was defined as the lowest disinfectant concentration with the
capacity to inhibit glucuronidase activity.
RESULTS
The antibacterial activities of the four disinfect-
ants, as determined with the fluorescence bioas-
say based on the glucuronidase activity of E. coli,
are shown in Fig. 1. HP had the least inhibitory
effect on glucuronidase activity, with a concen-
tration of > 300 mg ⁄L being required to inhibit
glucuronidase activity by 50%. In contrast, OPA
and BNP produced 50% inhibition at concentra-
tions of c. 1 mg ⁄L, while the corresponding
concentration of GTA was c. 20 mg ⁄L.
According to the results of the toxicity bioassay,
OPA and BNP were also the two substances that
showed the greatest inhibitory effect (p < 0.05) on
the glucuronidase activity of E. coli at the lowest
concentrations. Higher concentrations of HP (up
to 300-fold and 60-fold greater, respectively) and
GTA (up to 20-fold and four-fold greater, respect-
ively) were required to produce the same effect as
BNP or OPA. The lowest concentrations at which
the four test disinfectants were capable of inhib-
iting the glucuronidase activity of E. coli are
shown in Table 1.
In the tests conducted to estimate the quantity
of disinfectant released by each of the test mate-
rials, some residual inhibitory activity was detec-
ted with all five of the materials. Only OPA 0.5%
v ⁄ v on latex and cotton, and HP 3% v ⁄ v on
polypropylene and cotton, failed to show signifi-
cant levels of inhibition (Table 2). The highest
inhibitory activity was detected on glass disinfec-
ted with OPA 0.5% v ⁄v, and polyurethane and
latex disinfected with HP 3% v ⁄ v.
DISCUSSION
This study examined the residual toxic activity
on five clinical materials of four disinfectants
used commonly in hospitals. Although safety
limits for the residual presence of BNP, GTA,
HP or OPA on disinfected clinical materials
have not been established, toxicity data are
available [12].
In the hospital environment, use of BNP is
confined to surface disinfection in high-risk areas.
Bearing in mind its low working concentration
(0.1% v ⁄ v), its exclusive use as a disinfectant of
inert surfaces, its low toxicity [12] and the low
residual levels of BNP detected in the fluores-
cence bioassay (0.002–0.226 lg ⁄ cm2), its use is
unlikely to pose a health risk for patients or
medical staff exposed to surfaces disinfected with
this substance.
GTA, OPA and HP are used for the high-
level disinfection of clinical devices and other
hospital materials—e.g., probes, catheters or
endoscopes—that come into contact with the
mucous membranes of patients. GTA is prob-
ably the substance that has been associated most
often with undesirable effects in patients. How-
ever, the individuals with the highest risk of
exposure to this substance in the hospital
environment are the personnel who use it for
the sterilisation of medical equipment or as a
laboratory reagent, to the extent that discon-
tinuation of its use has been proposed [13]. As
shown in Table 2, the least porous materials
disinfected with GTA—polyurethane, polypro-
pylene and glass—had greater residual inhibi-
tory activity, which would correspond to a
greater concentration of released disinfectant.
In theory, 0.25 mg of disinfectant could be
released after vigorous vortexing for 10 s of a
100-cm polyurethane catheter treated previously
with GTA 2% v ⁄ v (Table 2). For a patient with
a body weight of 60 kg, this would mean an
intake of 0.002 mg ⁄ kg body weight, which is far
below the established toxicity level [12]. The
residual quantities released by the other test
materials would be similar or even less.
More recently, OPA or HP—as gas plasma—
have been suggested as alternatives to GTA 2%
v ⁄v for high-level disinfection [14]. Although
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OPA may pose occupational hazards similar to
those of GTA, the risk is reduced significantly by
the low active concentration of OPA [15] and the
relatively low vapour pressure of OPA-based
commercial products. HP is a natural substance
that leaves no potentially hazardous residues at
the end of a sterilisation process [16]. Undesir-
able effects as a consequence of patients coming
into contact with materials sterilised with HP
have seldom been observed [17]. According to
the results of the toxicity bioassay, the highest
levels of toxicity (5.184, 3.681 and 1.761 lg ⁄ cm2,
respectively) were detected for OPA and HP
(Table 2). The porous materials (latex and cotton)
were the materials with the lowest residual
concentrations of OPA. Polypropylene and cot-
ton had the lowest residual concentrations of
HP.
As with GTA, the quantities of HP and OPA
released by a 100-cm fragment of any of the test
materials would be significantly below the
established toxicity level [12]. However, it is
important to note that the conditions used for
the assay in the present study represent an
artificial situation. Actual patient exposure
would be difficult to determine, since, in addi-
tion to the type of material and disinfectant
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Fig. 1. Effects of glutaraldehyde, o-phthalaldehyde, 2-bromo-2-nitro-1,3-propanediol and hydrogen peroxide on Escherichia
coli b-glucuronidase activity. The symbols represent the individual five replicate tests conducted with each disinfectant.
Table 1. Lowest concentrations of the four test disinfect-
ants that inhibited the glucuronidase activity of Escherichia
coli, as measured by the fluorescence assaya
Disinfectant
Concentration
(mg ⁄L)
Mean percentage
inhibition ± SD pb
2-bromo-2-nitro-1,3-propanediol 0.001 17.98 ± 6.26 0.0007
Glutaraldehyde 0.02 9.61 ± 6.35 0.0105
Hydrogen peroxide 0.3 14.85 ± 7.16 0.0103
o-phthalaldehyde 0.005 11.12 ± 5.38 0.0007
aEffect is expressed as percentage inhibition of glucuronidase activity in relation to
controls without disinfectant. Five replicates were assayed with each disinfectant.
bStatistical significance compared to controls (without disinfectants); each param-
eter was analysed by paired Student’s t-test. p < 0.05 was considered to be
statistically significant.
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used, exposure would depend on the precise
clinical intervention (e.g., the duration of an
endoscopy procedure) and the surface area of
the disinfected material or device.
Other studies conducted with ethylene oxide or
using cytotoxicity tests have shown differ-
ences—which are sometimes quite consider-
able—in residue concentrations detected on
different materials [18,19]. Although the results
cannot be compared directly, since they are based
on different methods and chemicals, the findings
of the present study do not agree with these
previous results, insofar as it appeared that porous
materials picked up and retained more chemical
agents than non-porous materials. This may relate
to the fact that the present study measured the
concentrations of disinfectant agents released by
the test materials, rather than the concentrations of
agents adhering to them. Further studies are
currently in progress to analyse this difference.
The toxicity test used in this study permitted
the detection of very low disinfectant concentra-
tions—as residues present on disinfected materi-
als—released after shaking in an aqueous
medium for only 10 s. It was observed in a
previous study using different disinfectants that
an increase in the elution time did not produce a
significant increase in the elution of disinfectant
[11]. However, the toxicity test based on glucu-
ronidase activity is readily adaptable to different
circumstances and could be used as a rapid
screening method to determine the presence of
residual inhibitory activity stemming from the
use of disinfectants, and in studies designed to
establish the potential role of these residues in the
prevention of infections produced by pathogenic
microorganisms in hospitals.
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